← back to search

Leoni A. Kunz‐Schughart

Heidelberg University · DE
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Cancer Cells and Metastasis, Cancer Research and Treatments, and 3D Printing in Biomedical Research.
h-index
57
citations
19,072
works
238
NIH funding
primary concept
email

Recent publications

Generalized, sublethal damage-based mathematical approach for improved modeling of clonogenic survival curve flattening upon hyperthermia, radiotherapy, and beyond
Physics in Medicine and Biology 2025cited by 2position: lastdoi
Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma
Cancers 2022cited by 28position: middledoi
Targeting of p21-Activated Kinase 4 Radiosensitizes Glioblastoma Cells via Impaired DNA Repair
Cells 2022cited by 10position: middledoi
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
Theranostics 2021cited by 167position: middledoi
MISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity
Nature Methods 2021cited by 83position: middledoi
Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancer
Communications Biology 2021cited by 62position: middledoi
Models for Translational Proton Radiobiology—From Bench to Bedside and Back
Cancers 2021cited by 20position: middledoi
Efficient Heat Shock Response Affects Hyperthermia-Induced Radiosensitization in a Tumor Spheroid Control Probability Assay
Cancers 2021cited by 12position: lastdoi
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 12position: middledoi
Dual role of ER stress in response to metabolic co-targeting and radiosensitivity in head and neck cancer cells
Cellular and Molecular Life Sciences 2020cited by 19position: lastdoi
Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines
Theranostics 2020cited by 14position: lastdoi
The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity
Clinical Cancer Research 2019cited by 95position: middledoi
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin
Cancers 2019cited by 32position: middledoi
PO-247 Beneficial therapeutic ménage à trois: enzymotherapeutic arginine-deprivation, gemcitabine and proton irradiation for pancreatic cancer treatment - a systematic in vitro study
ESMO Open 2018cited by 1position: lastdoi
Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization
Molecular Cancer Therapeutics 2017cited by 37position: lastdoi
Iron chelators target both proliferating and quiescent cancer cells
Scientific Reports 2016cited by 74position: middledoi
The why and how of amino acid analytics in cancer diagnostics and therapy
Journal of Biotechnology 2016cited by 65position: lastdoi
Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells
Journal of Cancer 2016cited by 15position: middledoi
OS1.2 Effects of the IDH1R132H mutation on redox-status and metabolism are cell type dependent but independent from D-2-hydroxyglutarate accumulation
Neuro-Oncology 2016cited by 1position: middledoi
Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells
Cancer Research 2015cited by 220position: middledoi
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
Oncotarget 2015cited by 108position: middledoi
Potential of a Cetuximab‐based radioimmunotherapy combined with external irradiation manifests in a 3‐D cell assay
International Journal of Cancer 2014cited by 28position: lastdoi
Long-Term Results of Combined Modularized, Immune-Modulatory, Angiostatic, and Antiinflammatory Therapy in Systemically Pre-Treated Multi-Systems Langerhans Cell Histiocytosis
2013cited by 1position: middledoi
Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo
Strahlentherapie und Onkologie 2012cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anna Dubrovska · German Cancer Research Center6 papers (2015–2022)Michaël Baumann · European CanCer Organisation6 papers (2012–2020)Mechthild Krause · German Cancer Research Center4 papers (2015–2022)Ina Kurth · German Cancer Research Center4 papers (2015–2019)Steffen Löck · German Cancer Research Center4 papers (2017–2020) · 4 papers (2019–2021)Barbara Klink · University of Luxembourg3 papers (2016–2019)Nils Cordes · German Cancer Research Center3 papers (2014–2022)Achim Temme · German Cancer Research Center3 papers (2016–2019)Claudia Peitzsch · German Cancer Research Center3 papers (2015–2019)Susan Richter · University of Auckland2 papers (2019–2019) · 2 papers (2014–2017) · 2 papers (2015–2015) · 2 papers (2016–2020)Benedikt M. Kessler · University of Oxford2 papers (2016–2020)Lisa Eckhardt · German Cancer Research Center2 papers (2021–2025)Christel Herold‐Mende · German Cancer Research Center2 papers (2016–2019)Mirko Peitzsch · University Hospital Carl Gustav Carus2 papers (2016–2019) · 2 papers (2021–2025) · 2 papers (2017–2020)